CAS 1346599-56-1

Fórmula: C26H23ClN2O5

InChI: InChI=1S/C26H23ClN2O5/c1-15-5-3-4-6-19(15)25(33)28-18-8-9-20(16(2)13-18)26(34)29-22-10-7-17(27)14-21(22)23(30)11-12-24(31)32/h3-10,13-14H,11-12H2,1-2H3,(H,28,33)(H,29,34)(H,31,32)

Clave InChI: PRTSBHBGYFDAAS-UHFFFAOYSA-N

SMILES: CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)NC3=C(C=C(C=C3)Cl)C(=O)CCC(=O)O)C

Tolvaptan Open Ring Ketoacid (4-(5-chloro-2-(2-methyl-4-(2-methylbenzamido)benzamido)phenyl)-4-oxobutanoic acid)

CAS: 1346599-56-1

Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof, nesoi

Fórmula: C₂₆H₂₃ClN₂O₅

Forma y color: Off-White Solid

Peso molecular: 478.12955

Ref: 45-1A04720

Tolvaptan Impurity 1 (DM-4103)

CAS: 1346599-56-1

Fórmula: C₂₆H₂₃ClN₂O₅

Forma y color: White To Off-White Solid

Peso molecular: 478.93

Ref: 4Z-T-699

Tolvaptan γ-Oxobutanoic Acid Impurity

Producto controlado

CAS: 1346599-56-1

Fórmula: C₂₆H₂₃ClN₂O₅

Forma y color: Neat

Peso molecular: 478.924

Ref: TR-T536665

Tolvaptan gamma-oxobutanoic acid impurity

CAS: 1346599-56-1

Tolvaptan is a drug that is used for the treatment of hyponatremia. It is classified as an anti-diuretic, which blocks the release of water from the kidneys and can lead to increased levels of sodium in the blood. Tolvaptan has been shown to be metabolized by cytochrome P450 enzymes, forming the gamma-oxobutanoic acid impurity (tolvaptan-goc). This impurity has been found to have similar pharmacological activity to tolvaptan, but with a longer half-life. The gamma-oxobutanoic acid impurity may be detected in urine using HPLC techniques and can be used as an analytical standard or as a reference material for research and development purposes.

Fórmula: C₂₆H₂₃ClN₂O₅

Pureza: Min. 95%

Peso molecular: 478.90 g/mol

Ref: 3D-WDC59956

Tolvaptan Impurity 1

CAS: 1346599-56-1

Fórmula: C₂₆H₂₃ClN₂O₅

Peso molecular: 478.93

Ref: ST-EA-CP-T26011

DM-4103

CAS: 1346599-56-1

DM-4103 is a primary metabolite of Tolvaptan, predominantly metabolized by the CYP3A4 enzyme in the liver. In SCHH cells, DM-4103 inhibits the human liver transport proteins NTCP, BSEP, MRP2, MRP3, and MRP4 with IC50 values of 16.3, 4.15, 51.0, 44.6, and 4.26 μM, respectively, and affects bile acid transport. DM-4103 is applicable for research in autosomal dominant polycystic kidney disease (ADPKD).

Fórmula: C₂₆H₂₃ClN₂O₅

Peso molecular: 478.92

Ref: TM-T210591